Hemindra Hazari On How Brexit Could Impact Indian Markets

  • 26:13
  • Published On: June 27, 2016
Cinema View
Embed
Pharma and FMCG sectors may be safe havens in India as a result of Brexit, says market analyst Hemindra Hazari. Investors also have to be cautious on domestic plays as global slowdown may result in cheaper imports which may impact domestic production and sales, he adds.

Related Videos

Moderna Approved For Emergency Use, 4th Vaccine Okayed By India
June 30, 2021 0:35
The Biggest Stories Of June 29, 2021
June 29, 2021 16:55
Cipla Allowed To Import Moderna Vaccine For Use In India
June 29, 2021 3:38
Antibody Cocktail: All You Need To Know
June 01, 2021 5:27
Covid-19: Who Needs Antibody Cocktail?
June 01, 2021 26:53
'Cocktail Very Effective Against Various Variants': Roche Pharma India CEO
May 25, 2021 9:06
Sensex, Nifty Give Up Early Gains
June 14, 2017 2:24
Positive on Reliance Industries, NBFCs: Sajiv Dhawan
April 07, 2017 27:50
Buy VST Tillers Tractors, Cipla: Nirmal Bang
February 09, 2017 16:42
Big Opportunity For Arun Jaitley: Sajiv Dhawan
January 30, 2017 12:57
UK Approval For Seretide MDI: Cipla
December 27, 2016 7:20
Accumulate Two-Wheeler, Housing Finance Stocks: Sajiv Dhawan
November 18, 2016 26:27
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination